Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    gastroenterology

    Pancreatic exocrine insufficiency

    Also known as: Exocrine pancreatic insufficiency, EPI, PEI, Pancreatic enzyme insufficiency

    Pancreatic exocrine insufficiency (PEI) is characterized by an inadequate secretion or delivery of digestive enzymes, resulting in malabsorption. Clinical manifestations primarily include steatorrhoea, abdominal distension, unintentional weight loss, and secondary nutritional deficiencies. Primary management involves identifying the underlying aetiology, implementing pancreatic enzyme replacement therapy (PERT), and systematic nutritional surveillance. In Traditional Chinese Medicine (TCM), diagnostic patterns focus on symptomatic presentation rather than pancreatic pathophysiology or disease progression. While acupuncture may be considered as an adjunctive therapy for symptomatic support, the cited evidence does not demonstrate direct efficacy for PEI or its herbal management. Record [1] lacks an abstract, [2] addresses metabolic mechanisms, and [4] relates to postoperative nutrition rather than the treatment of PEI. Safety guidance represents general clinical precautions; associated citations indicate context rather than direct validation.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Maintain a systematic record of bowel frequency, steatorrhoea, distension, PERT compliance, and weekly body mass to facilitate clinical review.
    • •Ensure strict adherence to the prescribed pancreatic enzyme replacement therapy protocol; consult the medical team regarding any administration difficulties.
    • •Avoid self-imposed lipid restriction or other restrictive dietary habits; a referral to a dietitian is recommended to ensure adequate caloric and micronutrient intake.
    • •Cease tobacco use and consult with the clinical team regarding alcohol cessation, particularly in the presence of established pancreatic pathology.

    Cautions & Contraindications

    See sources
    • •Do not stop pancreatic enzymes, delay investigation of weight loss or substitute herbal products for medical nutritional management. Record [1] identifies PEI and enzyme therapy in its title but has no abstract and cannot substantiate detailed treatment guidance.[]
    • •Defer abdominal needling during unexplained acute pain, suspected obstruction or an unstable postoperative course. Avoid wounds, infected skin, drains and stomas. Record [4] provides postoperative context but does not study acupuncture safety.[]
    • •With severe malnutrition, dehydration or frailty, prioritise medical stabilisation before elective acupuncture or herbal prescribing. Record [4] discusses nutritional risk in postoperative populations; this precaution is not directly tested there.[]
    • •Do not extrapolate the time-restricted feeding discussion in [2] to underweight or malnourished people with PEI; fasting could further compromise intake. That review concerns obesity-related metabolic mechanisms, not a PEI nutritional protocol.[]

    When to reassess or seek care again

    See sources

    If medically stable, review adjunctive care after 2–4 weeks using stool frequency and greasiness, bloating severity on a 0–10 scale, food tolerance and weekly weight. Coordinate with the treating team on enzyme effectiveness and indicated nutritional blood tests. Refer earlier for ongoing weight loss, worsening diarrhoea or reduced intake; red flags require immediate escalation. Stop or reconsider adjunctive treatment if it causes adverse effects or offers no meaningful symptom benefit. Symptom improvement does not establish corrected malabsorption.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Pancreas · 2026
    2. World journal of methodology · 2026
    3. Translational gastroenterology and hepatology · 2026
    4. Frontiers in surgery · 2026

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.